Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

anti-human GITR monoclonal antibody TRX518

A humanized, Fc disabled anti-human glucocorticoid-induced tumor necrosis factor receptor (GITR) monoclonal antibody (MoAb) with immunomodulating activity. Anti-human GITR MoAb TRX518 blocks the interaction of GITR, found on multiple types of T cells, with its ligand, thereby inducing both the activation of tumor-antigen-specific T effector cells, as well as abrogating the suppression induced by inappropriately activated T-regulatory cells. This agent is shown to act synergistically with chemotherapeutic drugs in multiple cancer models.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Abbreviation:anti-huGITR MoAb TRX518
Code name:TRX518
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search